Author:
Lanzafame Massimiliano,Nicolè Stefano,Gibellini Davide,Lattuada Emanuela,Cucchetto Giulia,Rigo Fabio,Diani Erica,Concia Ercole,Vento Sandro
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)
Reference6 articles.
1. Dolutegravir monotherapy in HIV-infected naive patients with <100,000 copies/mL HIV RNA load;J Acquir Immune Defic Syndr,2016
2. . Long-term (96-week) follow-up of antiretroviral-naïve HIV-infected patients treated with first-line lopinavir/ritonavir monotherapy in the MONARK trial;for the MONARK Study Group;HIV Med,2010
3. Dolutegravir plus abacavir–lamivudine for the treatment of HIV-1 infection;N Engl J Med,2013
4. Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naïve adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study;Lancet,2014
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献